SCHEMBL26567798

SCHEMBL26567798

Cc1ccc(-c2ccc(-c3ccc4ccc(-c5ccc(C(F)(F)F)cc5)cc4c3)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.43
TDO2 P48775 1/20 0.43
KDM1A O60341 2/20 0.43
NPBWR1 P48145 2/20 0.43
MAOB P27338 1/20 0.43
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
KIF11 P52732 2/20 0.39
GAA P10253 2/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
TOP1 P11387 1/20 0.37
SDHB P21912 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548844 0.93 KDM1A (0.48) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26548354 0.88 KDM1A (0.49) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26567882 0.88 KDM1A (0.40) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26548850 0.88 TDO2 (0.45) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26548845 0.88 TDO2 (0.45) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26548843 0.87 KDM1A (0.44) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26548717 0.87 KIF11 (0.54) IDO1TDO2KDM1AMAOBKIF11
SCHEMBL26548833 0.87 KDM1A (0.44) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26567760 0.86 KDM1A (0.43) IDO1TDO2KDM1ANPBWR1MAOB
SCHEMBL26548847 0.86 TDO2 (0.45) IDO1TDO2KDM1AMAOBCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 IDO1 2053/4885TDO2 1074/4885KDM1A 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.